Towards a new treatment for equine acute laminitis: the importance of signalling pathways.

The research concerns the exploration of new treatments for equine acute laminitis, a common and debilitating disease in horses with limited effective therapies. The study focuses on understanding various theories related to pathogenesis, the involvement of certain mediators and vasoactive agents, and the in vitro effect of pentoxifylline, a non-specific inhibitor of phosphodiesterases, in equine digital vasculature.

Understanding the Pathogenesis of Laminitis

• The article explains theories previously proposed to understand the pathogenesis of laminitis, including inflammation, changes in the digital microvasculature, and the activation of degradative matrix metalloproteinases.
• A vascular theory was suggested, proposing that selected constriction of venules increases blood shunting, leading to laminar ischemia and subsequent reperfusion injury.

Existing Limitations in Therapy

• Despite evidence for the vascular theory, the study notes that current vaso-modulatory agents like acepromazine and glyceryl trinitrate have had limited therapeutic impact.
• There’s suggested evidence that the timing of drug administration also plays a crucial role in treatment effectiveness.

The Role of Vasoactive Mediators

• Research has been conducted to identify endogenous vasoactive mediators including norepinephrine, 5-hydroxytryptamine, thromboxane A 2, prostaglandin F 2a, and endothelin-1 that may play a key role in the condition’s pathophysiology.

Exploring the Effect of Pentoxifylline

• The researchers investigated the in vitro effect of pentoxifylline, a nonspecific inhibitor of phosphodiesterases, in the equine digital vasculature. This study found that pentoxifylline caused vasodilatation in equine digital veins.

Future Research Directions

• The study calls for further research to determine the effects of pentoxifylline on the more pathophysiological laminar vessels and to see if these in vitro effects can be translated into in vivo settings.
• The results of any such studies could potentially contribute to enhancing the treatment for equine acute laminitis.